Director, Discovery Sciences & Technologies
Revolution Medicines
About this role
Revolution Medicines is a clinical-stage oncology company focused on developing targeted therapies for RAS-related cancers. They are seeking a skilled drug discovery scientist to lead efforts across assay development, screening, and data analysis to support their growing oncology pipeline.
Skills
About Revolution Medicines
revmed.comRevolution Medicines (RevMed) is a biopharmaceutical company dedicated to discovering, developing, and delivering novel targeted medicines for patients with cancer. Their mission focuses specifically on "revolutionizing treatment for patients with RAS‑addicted cancers" through precision-targeted therapies. The company emphasizes a science-driven, end-to-end approach from discovery to delivery. RevMed brands its team as "Revolutionaries" committed to transforming outcomes for people with RAS‑driven tumors.
Recent company news
Investing.com2seventy bio completes merger with Bristol-Myers Squibb
May 13, 2025
Yahoo Finance2seventy bio Reports First Quarter Financial Results and Provides Update on Proposed Acquisition by Bristol Myers Squibb
May 7, 2025
Contract PharmaBristol Myers Squibb to Acquire 2seventy bio
Mar 13, 2025
Seeking AlphaBristol-Myers Squibb To Acquire 2seventy bio - A Sad But Inevitable End To A Cell Therapy Pioneer
Mar 12, 2025
BioWorld MedTechGene therapy efforts active, despite low Bluebird, 2seventy bids
Mar 14, 2025
About Revolution Medicines
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for Revolution Medicines.
Salary
$211k – $264k
per year
More jobs at Revolution Medicines
Similar Jobs
Associate Principal Scientist, Discovery Oncology
MSD
Senior Director, Cellular Assays
Relation Therapeutics
Research Scientist, Primary Pharmacology (18-month FTC)
Recursion
Senior Scientist - Targeted Protein Degradation
Amgen
Scientific Vice President, Lead Discovery & Optimization
0468 BMS Polska Sp. z o.o.
Staff Scientist, Molecular and Cellular Biology (industry experience required)
Septerna